“…Aside from acute regulation of terminal excitability and associated release, activation of D2Rs has been shown to drive posttranslational modifications to other regulators, such as DAT and vesicular monoamine transporter‐2 (VMAT2), leading to lasting alterations in transporter function and associated repackaging efficiency (Belin, Deroche‐Gamonet, & Jaber, 2007; Meiergerd, Patterson, & Schenk, 1993), an effect that alters the timing of dopamine release. Similarly, chronic activation of D2Rs can also induce morphological changes in dopaminergic axon growth and alterations in plasticity across multiple striatal subregions (Fasano, Kortleven, & Trudeau, 2010; Giguère et al., 2019; Parish, Finkelstein, Drago, Borrelli, & Horne, 2001; Parish et al., 2002; Tripanichkul, Stanic, Drago, Finkelstein, & Horne, 2003). These changes have important implications for subsequent terminal release events and dopamine‐mediated plasticity of other cell types across the brain as well.…”